HZNP   $116.3  0.04% Market Closed

Horizon Therapeutics Plc
Total Cash 2.48B
totalCashPerShare 10.85
EBITDA 669.21M
Total Debt 2.73B
quickRatio 3.489
currentRatio 4.274
Total Revenue 3.64B
debtToEquity 51.323
Revenue/Share 15.941
ROA 0.044359997
ROE 0.08541001
grossProfits 2.80B
freeCashflow 824.71M
operatingCashflow 1.04B
earningsGrowth 1.08
revenueGrowth 0.078
grossMargins 0.77362996
ebitdaMargins 0.18363
operatingMargins 0.17678
profitMargins 0.120179996
enterpriseValue 26.87B
forwardPE 20.547705
floatShares 211.06M
sharesOutstanding 229.00M
sharesShort 7.10M
sharesShortPriorMonth 7.86M
dateShortInterest
sharesPercentSharesOut 0.03%
heldPercentInsiders 0.01%
heldPercentInstitutions 1.01%
Short Ratio help_outline 2.04%
shortPercentOfFloat 0.03%
impliedSharesOutstanding
bookValue 23.198
Price To Book help_outline 5.01
earningsQuarterlyGrowth 1.08
netIncomeToCommon 438.00M
trailingEps 1.88%
forwardEps 5.66%
enterpriseToEbitda 40.16
lastDividendValue
lastDividendDate
currentQuarterEstimate 1.22 3Q 2023
institutionsCount 814
lastUpdated Dec. 6, 2023, 2:22 p.m.